Equities research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
CALA opened at $0.00 on Tuesday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.
About Calithera Biosciences
Further Reading
- Five stocks we like better than Calithera Biosciences
- How to start investing in penny stocks
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is the FTSE 100 index?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
